Form 4: Clorox Executive Kirsten Marriner Sells Shares Under Pre-Planned Trading Program
SEC Form 4
EVP and Chief People Officer of Clorox, Kirsten Marriner, sold shares of common stock on March 10th and 11th, 2025, under a pre-planned trading program.
Summary
- Kirsten Marriner, EVP Chief People Officer of Clorox, sold shares of Clorox common stock on March 10th and 11th, 2025.
- The sales were executed under a pre-planned trading program adopted on December 9th, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- On March 10th, 2025, a total of 7,494 shares were sold at weighted average prices ranging from $150.8501 to $153.4606.
- On March 11th, 2025, 733 shares were sold at a price of $150.
- Following these transactions, Marriner directly owns 26,305 shares of Clorox common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the stock sales were pre-planned and do not necessarily indicate a negative outlook on the company.
Positives
- The sales were conducted under a pre-planned trading program, suggesting they were not based on insider information or a sudden change in outlook.
Industry Context
Executive stock sales are a common occurrence in publicly traded companies. They are often part of a pre-planned strategy for personal financial management and diversification. It's important to consider the context of these sales, such as the existence of a 10b5-1 plan, to understand their potential implications.
Comparison to Industry Standards
- Executive stock sales are a normal part of compensation and portfolio management at publicly traded companies like Clorox.
- Comparable companies such as Procter & Gamble (PG) and Unilever (UL) also see regular Form 4 filings related to executive stock transactions.
- The volume and frequency of these sales are generally within expected ranges for executives at this level.
Stakeholder Impact
- The stock sales may have a minor impact on shareholders, but the pre-planned nature of the transactions suggests no significant concerns.
Key Dates
| Date | Description |
|---|---|
| 12/09/2024 | Date of adoption of the pre-planned trading program. |
| 03/10/2025 | Date of first stock sale. |
| 03/11/2025 | Date of second stock sale. |
| 03/12/2025 | Signature date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.